Research Comparison — Canada
Tirzepatide vs Semaglutide: Research Comparison for Canadian Labs
For in vitro laboratory research reference only. Both compounds are available from TrueCanPeptides for qualified laboratory use — shipped domestically across Canada.
The Core Difference: Receptor Breadth
Semaglutide is a GLP-1R monoagonist — its entire mechanism flows through a single receptor. Tirzepatide adds a second receptor target (GIPR), creating a dual-agonist profile that engages both the GLP-1 and GIP incretin pathways simultaneously. This is not merely additive biology — the two receptors are expressed in overlapping but distinct tissue distributions, meaning tirzepatide accesses adipose tissue biology through GIPR in ways semaglutide cannot.
| Research Parameter | Semaglutide | Tirzepatide |
|---|---|---|
| Receptor targets | GLP-1R | GLP-1R + GIPR |
| Scaffold | GLP-1 based (fatty acid conjugated) | GIP based (with GLP-1R activity) |
| Clinical trial programme | SUSTAIN, STEP | SURPASS, SURMOUNT |
| Adipose biology access | Via GLP-1R on adipocytes | Via GLP-1R + direct GIPR on adipocytes |
| Available in Canada | Buy Semaglutide → | Buy Tirzepatide → |
Research Literature Context
Head-to-head comparison in clinical research (SURPASS-CVOT and SURMOUNT vs STEP programmes) showed greater metabolic endpoint effects for tirzepatide than semaglutide. Mechanistically, this is attributed partly to tirzepatide’s GIPR agonism — particularly its effects on adipocyte lipid handling and hypothalamic satiety signalling through GIPR-expressing neurons.
For preclinical researchers, the two compounds serve complementary purposes: semaglutide for isolated GLP-1R pathway studies, tirzepatide for examining the additive contribution of GIPR co-stimulation. Comparing cell or animal responses to both compounds reveals which effects are GLP-1R-mediated versus GIPR-contributed.
Both available for laboratory research in Canada:
Related: Sema vs Tirze vs Reta | What Is Tirzepatide? | What Is Semaglutide? | Sema vs Ozempic
Research compounds only. Not for human administration. Not evaluated by Health Canada.